Translational Research Projects (TRP) in Spinal Cord Injury (Round 2)

Grants to New York Nonprofits and Agencies to
Research Treatments for Spinal Cord Trauma

Share it:

Agency Type:

State

Funding Source:

Add to My Calendar

New York State Department of Health (NYSDOH), New York State Spinal Cord Injury Research Board (SCIRB)

Conf. Date:

03/01/17

LOI Date:

02/24/17

Deadline Date:

04/28/17 4:00 PM EST

Description:

Request a Grant Writer

Grants to New York nonprofit organizations and government agencies for medical research addressing spinal cord injuries. LOIs are due February 24. Applicants must register by February 27 to attend the March 1 informational conference. Proposals will be considered for early translational research through pre-clinical research.

The SCIRB’s mission and goal is to:

1) Seek major advances toward a cure and not simply incremental research gains or incremental improvements for SCI patients.

2) Support research that tests novel hypotheses and/or advances innovative research approaches that could move the field of SCI research significantly toward discovering a cure for SCI.

The SCIRB’s mission is to stimulate high-quality, innovative SCI research that will help promote treatment and cure for SCI, including methods for reversing paralysis or restoring function caused by injury, or for minimizing or preventing damage occurring during acute phases of injury. To achieve this mission, the Program offers a of competitive research awards to support the New York State scientists and their collaborators from a variety of biomedical disciplines in initiating and pursuing such efforts.

Purpose of the Funds:

The SCIRB wishes to stimulate the growth of SCI research and to accelerate the pace with which basic (preclinical) findings are translated into clinical benefits for spinal cord-injured persons. In addition, SCIRB wishes to fill fundamental gaps in knowledge that are barriers to scientific advances in SCI research.

This Request for Applications (RFA) offers researchers the opportunity to advance well-proven hypotheses and early translational research findings into mid/late-stage translational and/or pre- clinical research that has a clear and feasible translational path to clinical application. The RFA also offers the opportunity to validate and optimize or iteratively refine devices, tools and technologies to treat or cure SCI paralysis in ways that significantly improve current capabilities.

GrantWatch ID#:

GrantWatch ID#: 157069

Estimated Total Program Funding:

$6,000,000

Number of Grants:

Up to 2

Estimated Size of Grant:

Annual direct costs are capped at $1,000,000.

Term of Contract:

The contract term will be up to five years. The project start date is January 1, 2018. Contracts will not be renewable.

Eligibility:

See RFP and/or Grant Guidelines for full eligibility

Additional Eligibility Criteria:

The applicant must be a not-for-profit organization or governmental organization in New York State. Awarded organizations will be expected to monitor the use of funds, maintain individual accounts and fulfill other fiscal management criteria. Subcontracting and collaborating organizations may include public, not-for-profit and for-profit entities within or outside of New York State.

The eligible Principal Investigator (PI) is designated by the application organization, has the skills, knowledge, and resources necessary to carry out the proposed Workplan, and is not a postdoctoral fellow or other dependent research staff.

An eligible organization is not limited to the number of applications it can submit in response to this RFA provided that each application is scientifically distinct. However, the eligible PI may submit only one application in response to this RFA, regardless of the organization under which (s)he submits the applications. If an eligible PI submits more than one application, all applications from that PI will be disqualified and will not be forwarded to peer review.

Eligibility to apply also includes the following mandatory items:
-The PI is not restricted from receiving Public Health Service (PHS) funding or debarred by the United States Food and Drug Administration (FDA) or any other federal or New York State government entity;
-The application does not propose support for a research center;
-The application does not propose support for a Phase III clinical trial;
-The application does not propose expansion of enrollment for an ongoing clinical trial;
-The PI has not submitted more than one application.

Submission of an application certifies that the applicant organization and the PI meet the eligibility criteria stated here.

Pre-proposal Conference:

An applicant conference will be held on March 1, 2017 at 10:30 AM EST to give potential applicants the opportunity to receive an overview of the RFA and ask specific questions. The conference will be held via telephone conference call.

The Department requests that potential applicants register for this conference by calling (518) 474- 7002 to ensure a sufficient number of conference phone lines. The deadline to register for the conference is February 27, 2017.

Conference Access:
-By telephone conference call at: 1-844-633-8697 or 1-866-776-3553
-Meeting ID # 318 999 801

Failure to attend the applicant conference will not preclude the submission of an application.

Pre-Application Information:

Timeline:
-Letter of Intent Due (Strongly encouraged): February 24, 2017
-Conflict of Interest Due (Optional): February 24, 2017
-Applicant Conference Registration Due: February 27, 2017
-Questions Due: March 3, 2017
-Questions, Answers and Updates Posted (on or about): March 8, 2017
-Applications Due: April 28, 2017: by 4:00 PM EST

Letter of Intent: The prospective applicant institution is strongly encouraged to complete and submit a Letter of Intent. Submission of a Letter of Intent is not a requirement or obligation upon the applicant to submit an application in response to this RFA.

Conflict of Interest: The SCIRB aims to conduct a review process that is rigorous and impartial. All participants in a review (including scientific reviewers, DOH staff members and members of the SCIRB) are required to disclose financial interests and declare all conflicts that meet relevant SCIRB and State of New York conflict of interest regulations.

View this opportunity on Grants Gateway: https://grantsgateway.ny.gov/intelligrants_NYSGG//module/nysgg/goportal.aspx?NavItem1=4&ngoID=5000728

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Charles J. Burns
(518) 474-7002
scirb@health.ny.gov

Extramural Grants Administration
New York State Department of Health
Wadsworth Center
Empire State Plaza, Room C345
PO Box 509, Albany, NY 12201-0509